ABSTRACT
BOTH topical and oral therapeutic agents introducedin the previous chapter have been shown to be of significant value in the treatment of rosacea. Clinical improvement, however, is usually most apparent in the inflammatory lesions associated with the disease, including papules and pustules, whereas the effect of these agents on erythema and especially telangiectasias tends to be limited at best. On the other hand, lasers and similar devices can predictably attain considerable amelioration in these latter lesions, thereby significantly improving the quality of life in rosacea patients, especially those with the erythematotelangiectatic subtype (Tan & Tope 2004).
